| PMC full text: | JAMA Oncol. Author manuscript; available in PMC 2018 Jan 8. Published in final edited form as: JAMA Oncol. 2016 Jul 1; 2(7): 929–936. doi: 10.1001/jamaoncol.2015.6478 |
Table 1
Point Assignments for the CPS+EG and Neo-Bioscore Staging Systems
| Cancer Stage | CPS+EG Points | Neo-Bioscore Points |
|---|---|---|
| Clinical stage | ||
 I | 0 | 0 |
| IIA | 0 | 0 |
| IIB | 1 | 1 |
| IIIA | 1 | 1 |
| IIIB | 2 | 2 |
| IIIC | 2 | 2 |
| Pathologic stage | ||
| 0 | 0 | 0 |
| I | 0 | 0 |
| IIA | 1 | 1 |
| IIB | 1 | 1 |
| IIIA | 1 | 1 |
| IIIB | 1 | 1 |
| IIIC | 2 | 2 |
| Tumor marker | ||
| ER negative | 1 | 1 |
| Grade 3 | 1 | 1 |
| ERBB2 negative | 1 |